ICU mortality · people admitted to intensive care units
It is very uncertain whether H2 receptor antagonists changes all‐cause mortality in ICU compared with antacids (very low certainty).
1 finding from 1 review
ICU mortality · people admitted to intensive care units
H2 receptor antagonists showed no clear difference in all‐cause mortality in ICU compared with sucralfate (low certainty).
1 finding from 1 review
ICU mortality · people admitted to intensive care units
Antacids showed no clear difference in all‐cause mortality in ICU compared with sucralfate (low certainty).
1 finding from 1 review
ICU mortality · people admitted to intensive care units
H2 receptor antagonists showed no clear difference in all‐cause mortality in ICU compared with placebo or no prophylaxis (low certainty).
1 finding from 1 review
Mortality before hospital discharge · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
It is very uncertain whether inhaled nitric oxide changes mortality prior to discharge1 compared with placebo or conventional therapy (very low certainty).
1 finding from 1 review
Mortality Total deaths at 30 days · acute bleeding gastric varices in people with portal hypertension
It is very uncertain whether cyanoacrylate changes mortality Total deaths at 30 days compared with alcohol (very low certainty).
1 finding from 1 review
Intervention not reported
Combined mortality of all studies · Adult patients in intensive care
The intervention leads to higher combined mortality of all studies (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total mortality Duration: 3.2 years · patients with hypertension
First‐line thiazides showed no clear difference in total mortality Duration: 3.2 years compared with first‐line alpha‐blockers (moderate certainty).
1 finding from 1 review
All‐cause mortality · people requiring tracheal intubation
Oxygenation showed no clear difference in mortality compared with no oxygenation during the apnoeic period preceding intubation (low certainty).
1 finding from 1 review
All‐cause mortality · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes participants with acute…
Enteral showed no clear difference in mortality compared with parenteral nutrition (low certainty).
1 finding from 1 review
All‐cause mortality · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes participants with acute…
Enteral showed no clear difference in mortality compared with enteral and parenteral nutrition (low certainty).
1 finding from 1 review
Intervention not reported
Mortality · people with severe traumatic brain injury (adults and children)
1 finding from 1 review
Intervention not reported
Mortality · critically ill patients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality at 31 to 100 days · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
It is very uncertain whether the intervention changes all‐cause mortality at 31 to 100 days (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 31 to 100 days · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
1 finding from 1 review
Total mortality Duration: 1 to 5 years · patients with hypertension
First‐line thiazides showed no clear difference in total mortality Duration: 1 to 5 years compared with first‐line ACE inhibitors (moderate certainty).
1 finding from 1 review
Total mortality Duration: 1 to 5 years · patients with hypertension
First‐line thiazides showed no clear difference in total mortality Duration: 1 to 5 years compared with first‐line calcium channel blockers (moderate certainty).
1 finding from 1 review
Total mortality Duration: 1 to 5.8 years · patients with hypertension
1 finding from 1 review
Composite infant mortality and morbidity · pregnant women with hypertensive disorders from 34 weeks' gestation to term
1 finding from 1 review